ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 571,44
-0,80%
Dow Jones
40 211,72
0,53%
DAX
18 504,99
-0,51%
Brent Oil
83,315
-1,22%
Bitcoin
63 425,33
-2,20%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Portola Pharmaceuticals Inc (PTLA)

  7. Portola Pharmaceuticals Inc (PTLA) Actualités

PTLA

Portola Pharmaceuticals (PTLA)

Portola Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PTLA
DateHeureSourceTitreSymboleSociété
09/12/201512h08Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PTLAPortola Pharmaceuticals Inc
08/12/201523h23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTLAPortola Pharmaceuticals Inc
05/12/201514h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Andexanet Alfa and Cerdulatinib Data Presentations at the 2015 American Society of Hematolo...NASDAQ:PTLAPortola Pharmaceuticals Inc
04/12/201523h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTLAPortola Pharmaceuticals Inc
04/12/201514h00GlobeNewswire Inc.Portola Announces Pricing of Public Offering of Common StockNASDAQ:PTLAPortola Pharmaceuticals Inc
03/12/201522h35GlobeNewswire Inc.Portola Pharmaceuticals Announces Proposed Offering of Common StockNASDAQ:PTLAPortola Pharmaceuticals Inc
12/11/201514h00GlobeNewswire Inc.Portola Pharmaceuticals to Host Analyst and Investor Day on November 19NASDAQ:PTLAPortola Pharmaceuticals Inc
11/11/201516h45GlobeNewswire Inc.The New England Journal of Medicine Publishes Results of Portola Pharmaceuticals’ Phase 3 ANNEXA Studies of Andexanet AlfaNASDAQ:PTLAPortola Pharmaceuticals Inc
09/11/201523h11Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:PTLAPortola Pharmaceuticals Inc
09/11/201523h07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTLAPortola Pharmaceuticals Inc
09/11/201522h05GlobeNewswire Inc.Portola Pharmaceuticals Reports Third Quarter 2015 Financial Results and Provides Corporate UpdateNASDAQ:PTLAPortola Pharmaceuticals Inc
06/11/201514h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Phase 3 ANNEXA™-R Part 2 Study Results to be Presented at American Heart Association Scie...NASDAQ:PTLAPortola Pharmaceuticals Inc
04/11/201514h00GlobeNewswire Inc.Portola Pharmaceuticals to Present at Credit Suisse 24th Annual Healthcare ConferenceNASDAQ:PTLAPortola Pharmaceuticals Inc
02/11/201514h00GlobeNewswire Inc.Portola Pharmaceuticals to Announce Third Quarter 2015 Financial Results and Host Conference Call on Monday, November 9NASDAQ:PTLAPortola Pharmaceuticals Inc
30/10/201513h00GlobeNewswire Inc.Portola Pharmaceuticals Completes Enrollment in Pivotal Phase 3 APEX Study of Betrixaban for Prevention of Blood Clots in Ac...NASDAQ:PTLAPortola Pharmaceuticals Inc
22/10/201515h02The Motley Fool3 Healthcare Trends Johnson & Johnson Told Us About This Earnings SeasonNASDAQ:PTLAPortola Pharmaceuticals Inc
18/10/201514h02The Motley Fool3 Biotech Long Shots That Could Be Worth Betting OnNASDAQ:PTLAPortola Pharmaceuticals Inc
13/10/201514h00GlobeNewswire Inc.Portola Pharmaceuticals Announces FDA Grants Fast Track Designation to Betrixaban for Prevention of Blood Clots in Acute Medi...NASDAQ:PTLAPortola Pharmaceuticals Inc
25/09/201519h02Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PTLAPortola Pharmaceuticals Inc
24/09/201523h31GlobeNewswire Inc.Portola Pharmaceuticals Appoints Dr. David C. Stump to Board of DirectorsNASDAQ:PTLAPortola Pharmaceuticals Inc
22/09/201502h46GlobeNewswire Inc.Portola Pharmaceuticals Announces Second Part of Phase 3 ANNEXA(TM)-R Study: Andexanet Alfa and Rivaroxaban Meets Primary and...NASDAQ:PTLAPortola Pharmaceuticals Inc
22/09/201502h46GlobeNewswire Inc.Portola Pharmaceuticals to Present at Morgan Stanley Global Healthcare ConferenceNASDAQ:PTLAPortola Pharmaceuticals Inc
07/08/201512h07Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:PTLAPortola Pharmaceuticals Inc
26/05/201517h33The Motley FoolPop! 3 To Buy If Biotech Stocks BurstNASDAQ:PTLAPortola Pharmaceuticals Inc
18/05/201514h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Upcoming Data Presentation on Dual Kinase Inhibitor Cerdulatinib at American Society of Cli...NASDAQ:PTLAPortola Pharmaceuticals Inc
11/05/201522h07Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PTLAPortola Pharmaceuticals Inc
06/05/201522h01GlobeNewswire Inc.Portola Pharmaceuticals Reports First Quarter 2015 Financial Results and Provides Corporate UpdateNASDAQ:PTLAPortola Pharmaceuticals Inc
05/05/201514h01GlobeNewswire Inc.Portola Pharmaceuticals Announces Collaboration With Ora, Inc. for Syk-selective Inhibitor (PRT2761) in Ophthalmic DiseasesNASDAQ:PTLAPortola Pharmaceuticals Inc
05/05/201500h33Analyst Ratings NetworkPortola Pharmaceuticals Downgraded to Sell at Zacks (PTLA)NASDAQ:PTLAPortola Pharmaceuticals Inc
03/05/201517h02The Motley FoolThe Tiny Biotech Getting Free Lunch from Big PharmaNASDAQ:PTLAPortola Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PTLA

Dernières Valeurs Consultées

LSE
JD.
Jd Sports Fashion
NASDAQ
AGNC
AGNC Investment
LSE
IGEA
Ishr Em A L G B
NASDAQ
LK
Luckin Coffee
USOTC
THPTF
Techpoint (PK)
LSE
CRN
Cairn Homes
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés